Pharmabiz32m
InflaRx receives European marketing authorization for Gohibicto treat of SARS-CoV-2-induced acute respiratory distress syndrome
InflaRx receives European marketing authorization for Gohibicto treat of SARS-CoV-2-induced acute respiratory distress syndrome: Jena, Germany Friday, January 17, 2025, 11:00 Hrs ...
Pharmabiz1h
UK MHRA publishes suite of guidance on new post-market surveillance regulation for medical devices
UK MHRA publishes suite of guidance on new post-market surveillance regulation for medical devices: United Kingdom Friday, January 17, 2025, 10:00 Hrs [IST] A suite of guidance ha ...
Pharmabiz2h
Innovent Biologics receives China NMPA breakthrough therapy designation for IBI343 as monotherapy for advanced pancreatic cancer
San Francisco, US Friday, January 17, 2025, 09:00 Hrs [IST] ...
Pharmabiz3h
Industry experts outline critical reforms for resilient, inclusive healthcare & pharma sector in Union Budget 2025-26
Shardul Nautiyal, Mumbai Friday, January 17, 2025, 08:00 Hrs [IST] ...
Pharmabiz3h
2024 annual report of Telangana DCA shows tenfold increase in seizures compared to previous year
Telangana DCA shows tenfold increase in seizures compared to previous year: Peethaambaran Kunnathoor, Chennai Friday, January 17, 2025, 08:00 Hrs [IST] The 2 ...
Pharmabiz3h
RGUHS forms IQAC to offset evolving academic-administrative challenges
RGUHS forms IQAC to offset evolving academic-administrative challenges: Nandita Vijayasimha, Bengaluru Friday, January 17, 2025, 08:00 Hrs [IST] In its efforts to foster and susta ...
Pharmabiz3h
Staff to student ratio for B.Pharm is minimum requirement, clarifies PCI
Staff to student ratio for B.Pharm is minimum requirement, clarifies PCI: Gireesh Babu, New Delhi Friday, January 17, 2025, ...
Pharmabiz3h
Industry expects incentivising research, streamlining taxation & fostering regulatory ease from Union Budget 2025
Industry expects incentivising research, streamlining taxation & fostering regulatory ease from Union Budget 2025: Our Bureau, New Delhi Friday, January 17, 2025, 08:00 Hrs [IST] ...
Pharmabiz17h
GenSight Biologics announces publication of 5-year outcomes for patients treated unilaterally with Lumevoq gene therapy
GenSight Biologics announces publication of 5-year outcomes for patients treated unilaterally with Lumevoq gene therapy: Paris, France Thursday, January 16, 2025, 18:00 Hrs [IST] ...
Pharmabiz18h
Annovis Bio’s buntanetap receives US patent for treatment and prevention of acute brain or nerve injuries
Annovis Bio’s buntanetap receives US patent for treatment and prevention of acute brain or nerve injuries: Malvern, Pennsylvania Thursday, January 16, 2025, 17:00 Hrs [IST] Anno ...
Pharmabiz19h
Vistagen reports positive results from exploratory phase 2A study of PH284 in cancer cachexia
Vistagen reports positive results from exploratory phase 2A study of PH284 in cancer cachexia: South San Francisco, California Thursday, January 16, 2025, 16:00 Hrs [IST] Vistagen ...
Pharmabiz20h
icotec gets US FDA 510(k) clearance for use of BlackArmor implants to treat de novo spinal infections
FDA clearance for the use of BlackArmor implants in the treatment of de novo spinal infections. icotec is honoured to be the first and only company in the United States with FDA 510(k) clearance for ...